This is Snapshot #3 for FHIR R5, released to support Connectathon 32. For a full list of available versions, see the Directory of published versions.
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative |
Raw JSON (canonical form + also see JSON Format Specification)
Definition for Code SystemFocusCharacteristicCode
{ "resourceType" : "CodeSystem", "id" : "focus-characteristic-code", "meta" : { "lastUpdated" : "2022-12-14T07:12:54.019+11:00", "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablecodesystem"] }, "text" : { "status" : "generated", "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>http://hl7.org/fhir/focus-characteristic-code</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">citation<a name=\"focus-characteristic-code-citation\"> </a></td><td>Citation</td><td>Used to reference a specific article.</td></tr><tr><td style=\"white-space:nowrap\">clinical-outcomes-observed<a name=\"focus-characteristic-code-clinical-outcomes-observed\"> </a></td><td>Observed outcomes are clinical outcomes</td><td>Used to denote a focus on clinical outcomes, ie evidence variable in role of outcome (measured variable) as observed is considered a "clinical outcome" (patient-important outcome such as mortality, symptoms, function or quality of life).</td></tr><tr><td style=\"white-space:nowrap\">population<a name=\"focus-characteristic-code-population\"> </a></td><td>Population</td><td>The population of interest.</td></tr><tr><td style=\"white-space:nowrap\">exposure<a name=\"focus-characteristic-code-exposure\"> </a></td><td>Exposure</td><td>The exposure of interest, such as an intervention.</td></tr><tr><td style=\"white-space:nowrap\">comparator<a name=\"focus-characteristic-code-comparator\"> </a></td><td>Comparator</td><td>The comparator (intervention or control state) of interest.</td></tr><tr><td style=\"white-space:nowrap\">outcome<a name=\"focus-characteristic-code-outcome\"> </a></td><td>Outcome</td><td>the outcome of interest.</td></tr><tr><td style=\"white-space:nowrap\">medication-exposures<a name=\"focus-characteristic-code-medication-exposures\"> </a></td><td>Medication exposures</td><td>Any medication exposures. A subset of exposures or interventions that are medications.</td></tr><tr><td style=\"white-space:nowrap\">study-type<a name=\"focus-characteristic-code-study-type\"> </a></td><td>Study type</td><td>Type of research study, such as randomized trial or case-control study.</td></tr></table></div>" }, "extension" : [{ "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg", "valueCode" : "cds" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status", "valueCode" : "trial-use" }, { "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger" : 0 }], "url" : "http://hl7.org/fhir/focus-characteristic-code", "identifier" : [{ "system" : "urn:ietf:rfc:3986", "value" : "urn:oid:2.16.840.1.113883.4.642.4.1960" }], "version" : "5.0.0-snapshot3", "name" : "FocusCharacteristicCode", "title" : "FocusCharacteristicCode", "status" : "active", "experimental" : false, "date" : "2020-12-28T16:55:11+11:00", "publisher" : "HL7 (FHIR Project)", "contact" : [{ "telecom" : [{ "system" : "url", "value" : "http://hl7.org/fhir" }, { "system" : "email", "value" : "fhir@lists.hl7.org" }] }], "description" : "Evidence focus characteristic code.", "jurisdiction" : [{ "coding" : [{ "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm", "code" : "001", "display" : "World" }] }], "caseSensitive" : true, "valueSet" : "http://hl7.org/fhir/ValueSet/focus-characteristic-code", "content" : "complete", "concept" : [{ "code" : "citation", "display" : "Citation", "definition" : "Used to reference a specific article." }, { "code" : "clinical-outcomes-observed", "display" : "Observed outcomes are clinical outcomes", "definition" : "Used to denote a focus on clinical outcomes, ie evidence variable in role of outcome (measured variable) as observed is considered a \"clinical outcome\" (patient-important outcome such as mortality, symptoms, function or quality of life)." }, { "code" : "population", "display" : "Population", "definition" : "The population of interest." }, { "code" : "exposure", "display" : "Exposure", "definition" : "The exposure of interest, such as an intervention." }, { "code" : "comparator", "display" : "Comparator", "definition" : "The comparator (intervention or control state) of interest." }, { "code" : "outcome", "display" : "Outcome", "definition" : "the outcome of interest." }, { "code" : "medication-exposures", "display" : "Medication exposures", "definition" : "Any medication exposures. A subset of exposures or interventions that are medications." }, { "code" : "study-type", "display" : "Study type", "definition" : "Type of research study, such as randomized trial or case-control study." }] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
FHIR ®© HL7.org 2011+. FHIR R5 Ballot hl7.fhir.core#5.0.0-snapshot3 generated on Wed, Dec 14, 2022 07:13+1100.
Links: Search |
Version History |
Contents |
Glossary |
QA |
Compare to R4B |
Compare to R5 Draft |
|
Propose a change